IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635
IDYA Stock | USD 25.70 0.77 3.09% |
About 54% of Ideaya Biosciences' investor base is interested to short. The analysis of the overall investor sentiment regarding Ideaya Biosciences suggests that many traders are impartial. The current market sentiment, together with Ideaya Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ideaya Biosciences stock news signals to limit their universe of possible portfolio assets.
Ideaya |
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on December 26, 2024, the Compensation Committee of IDEAYAs Board of Directors granted non-qualified stock options to purchase an aggregate of 31,400 shares of the Companys common stock to a newly hired employee. The stock options were granted under the IDEAYA Biosciences, Inc. 2023 Employment Inducement Incentive Award Plan
Read at finance.yahoo.com
Ideaya Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Ideaya Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ideaya Biosciences Fundamental Analysis
We analyze Ideaya Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ideaya Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ideaya Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Ideaya Biosciences is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Ideaya Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ideaya Biosciences stock to make a market-neutral strategy. Peer analysis of Ideaya Biosciences could also be used in its relative valuation, which is a method of valuing Ideaya Biosciences by comparing valuation metrics with similar companies.
Peers
Ideaya Biosciences Related Equities
SNDX | Syndax Pharmaceuticals | 5.59 | ||||
MGTX | MeiraGTx Holdings | 3.40 | ||||
MLTX | MoonLake Immunotherapeuti | 2.13 | ||||
RVMD | Revolution Medicines | 1.32 | ||||
KROS | Keros Therapeutics | 1.21 | ||||
PTGX | Protagonist Therapeutics | 0.23 | ||||
ANAB | AnaptysBio | 0.15 | ||||
SWTX | SpringWorks Therapeutics | 0.03 | ||||
RNA | Avidity Biosciences | 0.34 | ||||
VRNA | Verona Pharma | 1.23 | ||||
AMLX | Amylyx Pharmaceuticals | 1.56 | ||||
ABOS | Acumen Pharmaceuticals | 1.71 | ||||
INZY | Inozyme Pharma | 1.77 | ||||
VTYX | Ventyx Biosciences | 1.79 | ||||
DAWN | Day One | 2.25 | ||||
TERN | Terns Pharmaceuticals | 4.16 | ||||
XFOR | X4 Pharmaceuticals | 9.88 |
Complementary Tools for Ideaya Stock analysis
When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |